日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Deciphering the intratumor microbiota in malignant gastrointestinal tumors: multifaceted interplay and clinical implications

解析恶性胃肠道肿瘤的肿瘤内微生物群：多方面的相互作用及其临床意义

期刊:Cell Communication and Signaling
影响因子:8.9
doi:10.1186/s12964-025-02303-y
Tang, Bufu; Lin, Yaling; Jiang, Tong; Chen, Yixing; Zhao, Qianqian; Wang, Shuxuan; Shen, Yang; Wang, Siwei; Wu, Qiqiao; Xie, Pengjun; Zeng, Zhaochong; Du, Shisuo
微生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial

针对接受抗PD-1/PD-L1免疫疗法治疗的晚期/复发性食管癌患者的精准姑息治疗（ESO-上海25）：一项随机、III期试验

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2637738
Hao, Shengnan; Wang, Xiaomin; Ding, Huiping; Chen, Yun; Liu, Qi; Zhang, Junhua; Fan, Xingwen; Wu, Zhenhua; Lin, Ying; Xu, Xiaofang; Mao, Guangmin; Ai, Dashan; Deng, Jiaying; Zhu, Hongcheng; Ye, Jinjun; Mo, Miao; Hu, Zhihuang; Wang, Huijie; Cheng, Wenwu; Feng, Wei; Ling, Yiqun; Xu, Yufen; Du, Shisuo; Wang, Jialei; Zhao, Kuaile
肿瘤
肿瘤免疫
PD-L1
食管癌
PD-1
免疫/内分泌
发表日期：2026
文献求助 收藏

Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis

癌细胞来源的外泌体 circTMEM56 通过 miR-136-5p/STING 轴增强肝细胞癌放射治疗的疗效。

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2024.0544
Yuan, Li; Wang, Yue; Cheng, Junjie; Lin, Shilin; Ma, Aying; Li, Kunchao; Zheng, Yiming; Zeng, Zhaochong; Ke, Aiwu; Gao, Chao; Du, Shisuo
外泌体
肿瘤
肿瘤免疫
STING
细胞生物学
发表日期：2025
文献求助 收藏

Metformin reverses 5-FU resistance induced by radiotherapy through mediating folate metabolism in colorectal cancer.

二甲双胍通过调节结直肠癌中的叶酸代谢来逆转放射治疗引起的 5-FU 耐药性

期刊:Molecular Medicine
影响因子:6.4
doi:10.1186/s10020-025-01206-5
Wang Shuxuan, Lin Yanyan, Zhao Qianqian, Chen Huanliang, Du Shisuo, Zeng Zhaochong
代谢
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Increased IFN-β indicates better survival in hepatocellular carcinoma treated with radiotherapy.

IFN-β 水平升高表明接受放射治疗的肝细胞癌患者生存率更高

期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1093/cei/uxae075
Zhang Yang, Hong Weifeng, Zheng Danxue, Li Zongjuan, Hu Yong, Chen Yixing, Yang Ping, Zeng Zhaochong, Du Shisuo
细胞生物学
发表日期：2024
文献求助 收藏

Effect of Serum Interleukin-6 Concentration on the Prognosis After Radiotherapy for Patients With Hepatocellular Carcinoma

血清白细胞介素-6浓度对肝细胞癌患者放疗后预后的影响

期刊:Canadian Journal of Gastroenterology and Hepatology
影响因子:2.3
doi:10.1155/cjgh/4696097
Hu, Yong; Zhou, Yongkang; Du, Shisuo; Zhu, Wenchao; Chen, Yixing; Zeng, Zhaochong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof

比较螺旋断层立体定向放射治疗（SBRT）治疗早期肺癌（有或无病理学证据）的长期疗效

期刊:Radiation Oncology
影响因子:3.2
doi:10.1186/s13014-023-02229-0
Fan, Shaonan; Zhang, Qi; Chen, Jingyao; Chen, Gang; Zhu, Jiangyi; Li, Tingting; Xiao, Han; Du, Shisuo; Zeng, Zhaochong; He, Jian
肺癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Development and validation of a random forest model for predicting radiation pneumonitis in lung cancer patients receiving moderately hypofractionated radiotherapy: a retrospective cohort study

建立和验证随机森林模型预测接受中度低分割放疗的肺癌患者放射性肺炎：一项回顾性队列研究

期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm-22-3049
Zhang, Yang; Li, Zongjuan; Xiao, Han; Li, Zhenjiang; He, Jian; Du, Shisuo; Zeng, Zhaochong
肺炎
肺癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Induction Strategy for Locally Advanced Thymoma

局部晚期胸腺瘤的诱导治疗策略

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.704220
Zhang, Yang; Li, Zongjuan; Chen, Yixing; Tan, Lijie; Zeng, Zhaochong; Ding, Jianyong; Du, Shisuo
胸腺瘤
发表日期：2021
文献求助 收藏

Outcomes of Image-Guided Moderately Hypofractionated Radiotherapy for Stage III Non-Small-Cell Lung Cancer

影像引导下中度低分割放射治疗III期非小细胞肺癌的疗效

期刊:Journal of Oncology
影响因子:
doi:10.1155/2021/2721261
Zhang, Yang; Li, Zongjuan; Chen, Yixing; Xiao, Han; Zhou, Yongkang; Du, Shisuo; Zeng, Zhaochong
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏